Definium Therapeutics, Inc. (DFTX)
22.10
+0.17
(+0.78%)
USD |
NASDAQ |
Apr 15, 14:32
Definium Therapeutics EPS Diluted (Quarterly) : -0.5106 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pulse Biosciences, Inc. | -0.2572 |
| RxSight, Inc. | -0.2223 |
| Plus Therapeutics, Inc. | -1.03 |
| Viridian Therapeutics, Inc. | -1.080 |
| Nutriband, Inc. | -0.3212 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.44M |
| Total Expenses (Quarterly) | 50.44M |
| Enterprise Value | 1.815B |
| Earnings Yield | -9.36% |
| Normalized Earnings Yield | -8.547 |